{"id":2802,"date":"2021-10-15T10:49:05","date_gmt":"2021-10-15T10:49:05","guid":{"rendered":"https:\/\/aceoncology.org\/?p=2802"},"modified":"2021-10-25T07:27:46","modified_gmt":"2021-10-25T07:27:46","slug":"pembrolizumab-combination-is-changing-practice-in-first-line-management-of-advanced-cervical-cancer","status":"publish","type":"post","link":"https:\/\/aceoncology.org\/zh-hans\/pembrolizumab-combination-is-changing-practice-in-first-line-management-of-advanced-cervical-cancer\/","title":{"rendered":"\u5e15\u535a\u5229\u73e0\u5355\u6297\u8054\u5408\u6cbb\u7597\u66f4\u65b0\u665a\u671f\u5bab\u9888\u764c\u4e34\u5e8a\u5b9e\u8df5"},"content":{"rendered":"\n<p>\u96be\u6cbb\u6027\u3001\u590d\u53d1\u6027\u6216\u8f6c\u79fb\u6027\u5bab\u9888\u764c\u7684\u4e00\u7ebf\u6807\u51c6\u6cbb\u7597\u662f\u542b\u94c2\u5316\u7597\u00b1\u8d1d\u4f10\u73e0\u5355\u6297\u3002\u5c3d\u7ba1\u5728\u542b\u94c2\u4e00\u7ebf\u5316\u7597\u57fa\u7840\u4e0a\u52a0\u7528\u8d1d\u4f10\u73e0\u5355\u6297\u6539\u5584\u4e86\u751f\u5b58\u671f\uff08<a href=\"https:\/\/www.nejm.org\/doi\/pdf\/10.1056\/NEJMoa1309748\">GOG 240<\/a>\uff09\uff0c\u4f46\u665a\u671f\u5bab\u9888\u764c\u7684\u9884\u540e\u4ecd\u7136\u8f83\u5dee\uff0c\u4ecd\u5f85\u66f4\u4f18\u7684\u7597\u6cd5\u6ee1\u8db3\u4e34\u5e8a\u9700\u6c42\u3002\u6700\u8fd1\uff0cPD-1\u6291\u5236\u5242\u5e15\u535a\u5229\u73e0\u5355\u6297\uff08<a href=\"https:\/\/ascopubs.org\/doi\/abs\/10.1200\/JCO.2018.36.15_suppl.5522\">KEYNOTE-158 study<\/a>\uff09\u548ccemiplimab\uff08<a href=\"https:\/\/www.annalsofoncology.org\/article\/S0923-7534(21)01147-9\/fulltext\">EMPOWER-Cervical 1<\/a>\uff09\u4f5c\u4e3a\u5355\u836f\u6cbb\u7597\u5728\u65e2\u5f80\u7ecf\u6cbb\u7684\u665a\u671f\u5bab\u9888\u764c\u4e2d\u663e\u793a\u51fa\u5353\u8d8a\u7684\u7597\u6548\u3002\u514d\u75ab\u6cbb\u7597\u7684\u4f5c\u7528\u76ee\u524d\u6b63\u5728\u591a\u9879\u4e00\u7ebf\u6cbb\u7597\u7684\u7814\u7a76\u63a5\u53d7\u8bc4\u4f30\u3002<\/p>\n\n\n\n<p>\u57282021\u5e74ESMO\u5927\u4f1a\u4e0a\uff0cNicoletta Colombo\u535a\u58eb\uff08\u6b27\u6d32\u80bf\u7624\u7814\u7a76\u6240IRCCS\u548c\u610f\u5927\u5229\u7c73\u5170\u6bd4\u5361\u53ef\u5927\u5b66\uff09\u4ecb\u7ecd\u4e86\u53cc\u76f2\u3001\u968f\u673a\u3001III\u671f<a href=\"https:\/\/s3.eu-central-1.amazonaws.com\/m-anage.com.storage.esmo\/static\/esmo2021_abstractsv2\/LBA2.html.pdf\">KEYNOTE-826<\/a>\u8bd5\u9a8c\u7684\u7b2c\u4e00\u6b21\u4e2d\u671f\u5206\u6790\u7ed3\u679c\uff0c\u8be5\u7814\u7a76\u8bc4\u4ef7\u4e86\u4e00\u7ebf\u5e15\u535a\u5229\u73e0\u5355\u6297\u8054\u5408\u5316\u7597\u00b1\u8d1d\u4f10\u73e0\u5355\u6297\u6cbb\u7597\u5bab\u9888\u764c\u7684\u7597\u6548\u548c\u5b89\u5168\u6027\u3002\u8be5\u7814\u7a76\u7684\u76f8\u5173\u7ed3\u679c\u540c\u6b65\u53d1\u8868\u5728<a href=\"https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa2112435\">\u300a\u65b0\u82f1\u683c\u5170\u533b\u5b66\u6742\u5fd7\u300b<\/a>\u4e0a\u3002\u8be5\u8bd5\u9a8c\u5165\u7ec4\u4e86617\u4f8b\u665a\u671f\u5bab\u9888\u764c\u60a3\u8005\uff0c\u968f\u673a\u63a5\u53d7\u5e15\u535a\u5229\u73e0\u5355\u6297\u6216\u5b89\u6170\u5242\u8054\u5408\u94c2\u7c7b\u4e3a\u57fa\u7840\u7684\u5316\u7597\u00b1\u8d1d\u4f10\u73e0\u5355\u6297\uff08\u7531\u7814\u7a76\u8005\u51b3\u5b9a\uff09\u3002\u6839\u636e\u8ba1\u5212\u7684\u8d1d\u4f10\u73e0\u5355\u6297\u6cbb\u7597\u3001\u8bca\u65ad\u65f6\u7684\u8f6c\u79fb\u6027\u75be\u75c5\u548cPD-L1\u5408\u5e76\u9633\u6027\u8bc4\u5206\uff08CPS\uff09\u5bf9\u60a3\u8005\u8fdb\u884c\u5206\u5c42\u3002\u53cc\u91cd\u4e3b\u8981\u7ec8\u70b9\u662f\u603b\u751f\u5b58\u671f\uff08OS\uff09\u548c\u65e0\u8fdb\u5c55\u751f\u5b58\u671f\uff08PFS\uff09\u3002\u4e2d\u4f4d\u968f\u8bbf\u65f6\u95f4\u4e3a22\u4e2a\u6708\u3002<\/p>\n\n\n\n<p>\u5728\u521d\u6b65\u5206\u6790\u65f6\uff0c\u5728CPS\u22651\u3001\u610f\u5411\u6cbb\u7597\uff08ITT\uff09\u548cCPS\u226510\u4eba\u7fa4\u4e2d\u4f9d\u6b21\u68c0\u9a8c\u4e86\u5316\u7597\u00b1\u8d1d\u4f10\u73e0\u5355\u6297\u6dfb\u52a0\u5e15\u535a\u5229\u73e0\u5355\u6297\u5728PFS\u548cOS\u65b9\u9762\u7684\u4f18\u6548\u6027\u3002\u503c\u5f97\u6ce8\u610f\u7684\u662f\uff0c89%\u7684\u60a3\u8005\u4e3aPD-L1\u9633\u6027\u80bf\u7624\uff0c\u5176\u4e2d\u7ea650%\u7684\u60a3\u8005CPS\u226510\u3002\u5728\u5316\u7597\u00b1\u8d1d\u4f10\u73e0\u5355\u6297\u57fa\u7840\u4e0a\u52a0\u7528\u5e15\u535a\u5229\u73e0\u5355\u6297\u663e\u8457\u6539\u5584\u4e86\u6240\u6709\u4eba\u7fa4\u7684PFS\uff1aPD-L1 CPS\u22651\u7684\u60a3\u8005\u4e2d\uff0c\u5e15\u535a\u5229\u73e0\u5355\u6297\u7ec4\u7684\u4e2d\u4f4dPFS\uff08mPFS\uff09\u4e3a10.4\u4e2a\u6708\uff0c\u5b89\u6170\u5242\u7ec4\u4e3a8.2\u4e2a\u6708\uff08HR\uff0c0.62\uff1bP &lt; 0.001\uff09\uff1b\u5bf9\u4e8eITT\u4eba\u7fa4\uff0cmPFS\u4e3a10.4\u4e2a\u6708vs 8.2\u4e2a\u6708\uff08HR\uff0c0.65\uff1bP &lt; 0.001\uff09\uff1b\u5bf9\u4e8eCPS\u226510\u7684\u60a3\u8005\uff0cmPFS\u5206\u522b\u4e3a10.4\u4e2a\u6708\u548c8.1\u4e2a\u6708\uff08HR\uff0c0.58\uff1bP &lt; 0.001\uff09\u3002\u540c\u6837\uff0c\u5728\u6240\u6709\u751f\u7269\u6807\u5fd7\u7269\u4eba\u7fa4\u4e2d\uff0c\u4e0e\u5b89\u6170\u5242\u76f8\u6bd4\uff0c\u52a0\u7528\u5e15\u535a\u5229\u73e0\u5355\u6297\u663e\u8457\u6539\u5584\u4e86OS\uff1a\u5bf9\u4e8ePD-L1 CPS\u22651\uff0c\u5e15\u535a\u5229\u73e0\u5355\u6297\u7ec4\u672a\u8fbe\u5230\uff08NR\uff09\u4e2d\u4f4dOS\uff08mOS\uff09\uff0c\u5b89\u6170\u5242\u7ec4\u4e3a16.3\u4e2a\u6708\uff08HR\uff0c0.64\uff1bP &lt; 0.001\uff09\uff1b\u5bf9\u4e8eITT\u4eba\u7fa4\uff0cmOS\u4e3a24.4\u4e2a\u6708vs 16.5\u4e2a\u6708\uff08HR\uff0c0.67\uff1bP &lt; 0.001\uff09\uff1b\u5bf9\u4e8eCPS\u226510\u4eba\u7fa4\uff0cmOS\u5206\u522b\u4e3aNR vs 16.4\u4e2a\u6708\uff08HR\uff0c0.61\uff1bP = 0.001\uff09\u3002\u5728\u6240\u6709\u9884\u5148\u89c4\u5b9a\u7684\u4e9a\u7ec4\uff08\u5305\u62ec\u63a5\u53d7\u5316\u7597\u8054\u5408\u6216\u4e0d\u8054\u5408\u8d1d\u4f10\u73e0\u5355\u6297\u6cbb\u7597\u7684\u4e9a\u7ec4\uff09\u4e2d\uff0c\u5e15\u535a\u5229\u73e0\u5355\u6297\u5728PFS\u548cOS\u65b9\u9762\u7684\u83b7\u76ca\u5747\u660e\u786e\u4e14\u57fa\u672c\u4e00\u81f4\u3002\u5728\u5316\u7597\u00b1\u8d1d\u4f10\u73e0\u5355\u6297\u57fa\u7840\u4e0a\u52a0\u7528\u5e15\u535a\u5229\u73e0\u5355\u6297\u4e5f\u4e0e\u8f83\u9ad8\u7684\u5ba2\u89c2\u7f13\u89e3\u7387\uff08ORR\uff09\u76f8\u5173\uff0c\u8303\u56f4\u4e3a\u5e15\u535a\u5229\u73e0\u5355\u6297\u7ec4\u768466-70%\uff08\u5b8c\u5168\u7f13\u89e3\/CR 21-23%\uff09\uff0c\u5b89\u6170\u5242\u7ec4\u768449-51%\uff08CR 11-13%\uff09\u3002\u6b64\u5916\uff0c\u5e15\u535a\u5229\u73e0\u5355\u6297\u7ec4\u7684\u4e2d\u4f4d\u7f13\u89e3\u6301\u7eed\u65f6\u95f4\u7ea6\u4e3a\u51762\u500d\u3002\u5e15\u535a\u5229\u73e0\u5355\u6297\u8054\u5408\u6cbb\u7597\u7684\u5b89\u5168\u6027\u53ef\u63a7\u3002\u5e15\u535a\u5229\u73e0\u5355\u6297\u7ec4\u548c\u5b89\u6170\u5242\u7ec4\u4e2d3\u7ea7\u4ee5\u4e0a\u6cbb\u7597\u76f8\u5173\u4e0d\u826f\u4e8b\u4ef6\uff08TRAE\uff09\u7684\u53d1\u751f\u7387\u5206\u522b\u4e3a68.4%\u548c64.1%\u3002\u4e0e\u9884\u671f\u76f8\u540c\uff0c\u514d\u75ab\u4ecb\u5bfc\u7684AE\u5728\u5e15\u535a\u5229\u73e0\u5355\u6297\u8054\u5408\u6cbb\u7597\u7ec4\u4e2d\u7684\u53d1\u751f\u7387\u8f83\u9ad8\uff0833.9% vs 15.2%\uff09\uff0c\u6700\u5e38\u89c1\u7684\u662f\u7532\u72b6\u817a\u529f\u80fd\u51cf\u9000\u548c\u7532\u72b6\u817a\u529f\u80fd\u4ea2\u8fdb\u3002\u5e15\u535a\u5229\u73e0\u5355\u6297\u7ec4\u7ea6\u4e09\u5206\u4e4b\u4e00\u7684\u60a3\u8005\u56e0TRAE\u800c\u505c\u6b62\u6cbb\u7597\uff0831.3% vs 22.3%\uff09\u3002\u5e15\u535a\u5229\u73e0\u5355\u6297\u7ec4\u548c\u5b89\u6170\u5242\u7ec4\u56e0TRAE\u6b7b\u4ea1\u75c5\u4f8b\u5206\u522b\u4e3a2\u4f8b\u548c4\u4f8b\u3002\u91cd\u8981\u7684\u662f\uff0c\u52a0\u7528\u5e15\u535a\u5229\u73e0\u5355\u6297\u540e\u81f3\u751f\u6d3b\u8d28\u91cf\u8bc4\u5206\u6076\u5316\u7684\u65f6\u95f4\u4e5f\u663e\u8457\u6539\u5584\uff08HR\uff0c0.75\uff09\u3002<\/p>\n\n\n\n<p>Colombo\u535a\u58eb\u5f97\u51fa\u7ed3\u8bba\uff0c\u8fd9\u4e9b\u7ed3\u679c\u652f\u6301\u5728\u96be\u6cbb\u6027\u3001\u590d\u53d1\u6027\u6216\u8f6c\u79fb\u6027\u5bab\u9888\u764c\u60a3\u8005\u4e2d\u4f7f\u7528\u5e15\u535a\u5229\u73e0\u5355\u6297\u8054\u5408\u5316\u7597\u00b1\u8d1d\u4f10\u73e0\u5355\u6297\u3002\u8be5\u7814\u7a76\u7684\u8ba8\u8bba\u5609\u5bbeMansoor Raza Mirza\u535a\u58eb\uff08\u4e39\u9ea6\u54e5\u672c\u54c8\u6839\u5927\u5b66Rigshospitalet\u533b\u9662\uff09\u795d\u8d3a\u7814\u7a76\u8005\u83b7\u5f97\u4e86\u201c\u7a81\u7834\u6027\u201d\u548c\u201c\u6539\u53d8\u5b9e\u8df5\u201d\u7684\u7ed3\u679c\u3002\u7136\u800c\uff0c\u4ed6\u4e5f\u6307\u51fa\u4e86\u672a\u6765\u9700\u8981\u56de\u7b54\u7684\u51e0\u4e2a\u95ee\u9898\uff0c\u5305\u62ec\u5e15\u535a\u5229\u73e0\u5355\u6297\u8054\u5408\u5316\u7597\u5bf9\u539f\u53d1\u6027\u8f6c\u79fb\u6027\u75be\u75c5\u3001PD-L1\u9634\u6027\u60a3\u8005\u3001\u817a\u764c\u4ee5\u53ca\u4e0d\u8054\u5408\u8d1d\u4f10\u73e0\u5355\u6297\u7ed9\u836f\u662f\u5426\u6709\u6548\u3002<\/p>\n\n\n\n<p><strong>\u53c2\u8003\u6587\u732e<\/strong>:<br>Colombo N\uff0c et al. <em>ESMO<\/em> 2021\uff1b Abstract LBA2.<br>Colombo N\uff0c et al. <em>N Engl J Med<\/em>. 2021 Sep 18 [Online ahead of print].<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u96be\u6cbb\u6027\u3001\u590d\u53d1\u6027\u6216\u8f6c\u79fb\u6027\u5bab\u9888\u764c\u7684\u4e00\u7ebf\u6807\u51c6\u6cbb\u7597\u662f\u542b\u94c2\u5316\u7597\u00b1\u8d1d\u4f10\u73e0\u5355\u6297\u3002\u5c3d\u7ba1\u5728\u542b\u94c2\u4e00\u7ebf\u5316\u7597\u57fa\u7840\u4e0a\u52a0\u7528\u8d1d\u4f10\u73e0\u5355\u6297\u6539\u5584\u4e86 [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":2720,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[78],"tags":[],"class_list":["post-2802","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-78"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.8 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>\u5e15\u535a\u5229\u73e0\u5355\u6297\u8054\u5408\u6cbb\u7597\u66f4\u65b0\u665a\u671f\u5bab\u9888\u764c\u4e34\u5e8a\u5b9e\u8df5 - ACE Oncology<\/title>\n<meta name=\"description\" content=\"\u5e15\u535a\u5229\u73e0\u5355\u6297\u8054\u5408\u5316\u7597\u00b1\u8d1d\u4f10\u73e0\u5355\u6297\u6210\u4e3a\u665a\u671f\u5bab\u9888\u764c\u65b0\u6807\u51c6\u6cbb\u7597\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/aceoncology.org\/zh-hans\/pembrolizumab-combination-is-changing-practice-in-first-line-management-of-advanced-cervical-cancer\/\" \/>\n<meta property=\"og:locale\" content=\"zh_CN\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"\u5e15\u535a\u5229\u73e0\u5355\u6297\u8054\u5408\u6cbb\u7597\u66f4\u65b0\u665a\u671f\u5bab\u9888\u764c\u4e34\u5e8a\u5b9e\u8df5 - ACE Oncology\" \/>\n<meta property=\"og:description\" content=\"\u5e15\u535a\u5229\u73e0\u5355\u6297\u8054\u5408\u5316\u7597\u00b1\u8d1d\u4f10\u73e0\u5355\u6297\u6210\u4e3a\u665a\u671f\u5bab\u9888\u764c\u65b0\u6807\u51c6\u6cbb\u7597\" \/>\n<meta property=\"og:url\" content=\"https:\/\/aceoncology.org\/zh-hans\/pembrolizumab-combination-is-changing-practice-in-first-line-management-of-advanced-cervical-cancer\/\" \/>\n<meta property=\"og:site_name\" content=\"ACE Oncology\" \/>\n<meta property=\"article:published_time\" content=\"2021-10-15T10:49:05+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-10-25T07:27:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/10\/Picture-Blog-Post-61_Pembrizumab-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1736\" \/>\n\t<meta property=\"og:image:height\" content=\"1528\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"ACE Demo\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ace_oncology\" \/>\n<meta name=\"twitter:site\" content=\"@ace_oncology\" \/>\n<meta name=\"twitter:label1\" content=\"\u4f5c\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"ACE Demo\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 \u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/pembrolizumab-combination-is-changing-practice-in-first-line-management-of-advanced-cervical-cancer\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/pembrolizumab-combination-is-changing-practice-in-first-line-management-of-advanced-cervical-cancer\/\"},\"author\":{\"name\":\"ACE Demo\",\"@id\":\"https:\/\/aceoncology.org\/#\/schema\/person\/b551dd0a4b75a5b349e0a71560a8b3c0\"},\"headline\":\"\u5e15\u535a\u5229\u73e0\u5355\u6297\u8054\u5408\u6cbb\u7597\u66f4\u65b0\u665a\u671f\u5bab\u9888\u764c\u4e34\u5e8a\u5b9e\u8df5\",\"datePublished\":\"2021-10-15T10:49:05+00:00\",\"dateModified\":\"2021-10-25T07:27:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/pembrolizumab-combination-is-changing-practice-in-first-line-management-of-advanced-cervical-cancer\/\"},\"wordCount\":105,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/aceoncology.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/pembrolizumab-combination-is-changing-practice-in-first-line-management-of-advanced-cervical-cancer\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/10\/Picture-Blog-Post-61_Pembrizumab-1.jpg\",\"articleSection\":[\"\u4f1a\u8bae\u901f\u9012\"],\"inLanguage\":\"zh-Hans\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/aceoncology.org\/zh-hans\/pembrolizumab-combination-is-changing-practice-in-first-line-management-of-advanced-cervical-cancer\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/pembrolizumab-combination-is-changing-practice-in-first-line-management-of-advanced-cervical-cancer\/\",\"url\":\"https:\/\/aceoncology.org\/zh-hans\/pembrolizumab-combination-is-changing-practice-in-first-line-management-of-advanced-cervical-cancer\/\",\"name\":\"\u5e15\u535a\u5229\u73e0\u5355\u6297\u8054\u5408\u6cbb\u7597\u66f4\u65b0\u665a\u671f\u5bab\u9888\u764c\u4e34\u5e8a\u5b9e\u8df5 - ACE Oncology\",\"isPartOf\":{\"@id\":\"https:\/\/aceoncology.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/pembrolizumab-combination-is-changing-practice-in-first-line-management-of-advanced-cervical-cancer\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/pembrolizumab-combination-is-changing-practice-in-first-line-management-of-advanced-cervical-cancer\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/10\/Picture-Blog-Post-61_Pembrizumab-1.jpg\",\"datePublished\":\"2021-10-15T10:49:05+00:00\",\"dateModified\":\"2021-10-25T07:27:46+00:00\",\"description\":\"\u5e15\u535a\u5229\u73e0\u5355\u6297\u8054\u5408\u5316\u7597\u00b1\u8d1d\u4f10\u73e0\u5355\u6297\u6210\u4e3a\u665a\u671f\u5bab\u9888\u764c\u65b0\u6807\u51c6\u6cbb\u7597\",\"breadcrumb\":{\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/pembrolizumab-combination-is-changing-practice-in-first-line-management-of-advanced-cervical-cancer\/#breadcrumb\"},\"inLanguage\":\"zh-Hans\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/aceoncology.org\/zh-hans\/pembrolizumab-combination-is-changing-practice-in-first-line-management-of-advanced-cervical-cancer\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/pembrolizumab-combination-is-changing-practice-in-first-line-management-of-advanced-cervical-cancer\/#primaryimage\",\"url\":\"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/10\/Picture-Blog-Post-61_Pembrizumab-1.jpg\",\"contentUrl\":\"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/10\/Picture-Blog-Post-61_Pembrizumab-1.jpg\",\"width\":1736,\"height\":1528},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/pembrolizumab-combination-is-changing-practice-in-first-line-management-of-advanced-cervical-cancer\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"ACE Oncology\",\"item\":\"https:\/\/aceoncology.org\/zh-hans\/chinese-home\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"\u5e15\u535a\u5229\u73e0\u5355\u6297\u8054\u5408\u6cbb\u7597\u66f4\u65b0\u665a\u671f\u5bab\u9888\u764c\u4e34\u5e8a\u5b9e\u8df5\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/aceoncology.org\/#website\",\"url\":\"https:\/\/aceoncology.org\/\",\"name\":\"ACE Oncology\",\"description\":\"ACE Oncology is a global independent medical education resource that provides evidence-based, high-quality educational solutions for clinicians that treat patients with cancer.\",\"publisher\":{\"@id\":\"https:\/\/aceoncology.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/aceoncology.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"zh-Hans\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/aceoncology.org\/#organization\",\"name\":\"ACE Oncology\",\"url\":\"https:\/\/aceoncology.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\/\/aceoncology.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/05\/Logo.png\",\"contentUrl\":\"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/05\/Logo.png\",\"width\":156,\"height\":83,\"caption\":\"ACE Oncology\"},\"image\":{\"@id\":\"https:\/\/aceoncology.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/x.com\/ace_oncology\",\"https:\/\/www.linkedin.com\/company\/aceoncology\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/aceoncology.org\/#\/schema\/person\/b551dd0a4b75a5b349e0a71560a8b3c0\",\"name\":\"ACE Demo\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\/\/aceoncology.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/5364d75bb683367c9b56b8d9914df888527c9d170b78bbc5ef94bb01125a2253?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/5364d75bb683367c9b56b8d9914df888527c9d170b78bbc5ef94bb01125a2253?s=96&d=mm&r=g\",\"caption\":\"ACE Demo\"},\"url\":\"https:\/\/aceoncology.org\/zh-hans\/author\/demo\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u5e15\u535a\u5229\u73e0\u5355\u6297\u8054\u5408\u6cbb\u7597\u66f4\u65b0\u665a\u671f\u5bab\u9888\u764c\u4e34\u5e8a\u5b9e\u8df5 - ACE Oncology","description":"\u5e15\u535a\u5229\u73e0\u5355\u6297\u8054\u5408\u5316\u7597\u00b1\u8d1d\u4f10\u73e0\u5355\u6297\u6210\u4e3a\u665a\u671f\u5bab\u9888\u764c\u65b0\u6807\u51c6\u6cbb\u7597","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/aceoncology.org\/zh-hans\/pembrolizumab-combination-is-changing-practice-in-first-line-management-of-advanced-cervical-cancer\/","og_locale":"zh_CN","og_type":"article","og_title":"\u5e15\u535a\u5229\u73e0\u5355\u6297\u8054\u5408\u6cbb\u7597\u66f4\u65b0\u665a\u671f\u5bab\u9888\u764c\u4e34\u5e8a\u5b9e\u8df5 - ACE Oncology","og_description":"\u5e15\u535a\u5229\u73e0\u5355\u6297\u8054\u5408\u5316\u7597\u00b1\u8d1d\u4f10\u73e0\u5355\u6297\u6210\u4e3a\u665a\u671f\u5bab\u9888\u764c\u65b0\u6807\u51c6\u6cbb\u7597","og_url":"https:\/\/aceoncology.org\/zh-hans\/pembrolizumab-combination-is-changing-practice-in-first-line-management-of-advanced-cervical-cancer\/","og_site_name":"ACE Oncology","article_published_time":"2021-10-15T10:49:05+00:00","article_modified_time":"2021-10-25T07:27:46+00:00","og_image":[{"width":1736,"height":1528,"url":"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/10\/Picture-Blog-Post-61_Pembrizumab-1.jpg","type":"image\/jpeg"}],"author":"ACE Demo","twitter_card":"summary_large_image","twitter_creator":"@ace_oncology","twitter_site":"@ace_oncology","twitter_misc":{"\u4f5c\u8005":"ACE Demo","\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4":"1 \u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/aceoncology.org\/zh-hans\/pembrolizumab-combination-is-changing-practice-in-first-line-management-of-advanced-cervical-cancer\/#article","isPartOf":{"@id":"https:\/\/aceoncology.org\/zh-hans\/pembrolizumab-combination-is-changing-practice-in-first-line-management-of-advanced-cervical-cancer\/"},"author":{"name":"ACE Demo","@id":"https:\/\/aceoncology.org\/#\/schema\/person\/b551dd0a4b75a5b349e0a71560a8b3c0"},"headline":"\u5e15\u535a\u5229\u73e0\u5355\u6297\u8054\u5408\u6cbb\u7597\u66f4\u65b0\u665a\u671f\u5bab\u9888\u764c\u4e34\u5e8a\u5b9e\u8df5","datePublished":"2021-10-15T10:49:05+00:00","dateModified":"2021-10-25T07:27:46+00:00","mainEntityOfPage":{"@id":"https:\/\/aceoncology.org\/zh-hans\/pembrolizumab-combination-is-changing-practice-in-first-line-management-of-advanced-cervical-cancer\/"},"wordCount":105,"commentCount":0,"publisher":{"@id":"https:\/\/aceoncology.org\/#organization"},"image":{"@id":"https:\/\/aceoncology.org\/zh-hans\/pembrolizumab-combination-is-changing-practice-in-first-line-management-of-advanced-cervical-cancer\/#primaryimage"},"thumbnailUrl":"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/10\/Picture-Blog-Post-61_Pembrizumab-1.jpg","articleSection":["\u4f1a\u8bae\u901f\u9012"],"inLanguage":"zh-Hans","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/aceoncology.org\/zh-hans\/pembrolizumab-combination-is-changing-practice-in-first-line-management-of-advanced-cervical-cancer\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/aceoncology.org\/zh-hans\/pembrolizumab-combination-is-changing-practice-in-first-line-management-of-advanced-cervical-cancer\/","url":"https:\/\/aceoncology.org\/zh-hans\/pembrolizumab-combination-is-changing-practice-in-first-line-management-of-advanced-cervical-cancer\/","name":"\u5e15\u535a\u5229\u73e0\u5355\u6297\u8054\u5408\u6cbb\u7597\u66f4\u65b0\u665a\u671f\u5bab\u9888\u764c\u4e34\u5e8a\u5b9e\u8df5 - ACE Oncology","isPartOf":{"@id":"https:\/\/aceoncology.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/aceoncology.org\/zh-hans\/pembrolizumab-combination-is-changing-practice-in-first-line-management-of-advanced-cervical-cancer\/#primaryimage"},"image":{"@id":"https:\/\/aceoncology.org\/zh-hans\/pembrolizumab-combination-is-changing-practice-in-first-line-management-of-advanced-cervical-cancer\/#primaryimage"},"thumbnailUrl":"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/10\/Picture-Blog-Post-61_Pembrizumab-1.jpg","datePublished":"2021-10-15T10:49:05+00:00","dateModified":"2021-10-25T07:27:46+00:00","description":"\u5e15\u535a\u5229\u73e0\u5355\u6297\u8054\u5408\u5316\u7597\u00b1\u8d1d\u4f10\u73e0\u5355\u6297\u6210\u4e3a\u665a\u671f\u5bab\u9888\u764c\u65b0\u6807\u51c6\u6cbb\u7597","breadcrumb":{"@id":"https:\/\/aceoncology.org\/zh-hans\/pembrolizumab-combination-is-changing-practice-in-first-line-management-of-advanced-cervical-cancer\/#breadcrumb"},"inLanguage":"zh-Hans","potentialAction":[{"@type":"ReadAction","target":["https:\/\/aceoncology.org\/zh-hans\/pembrolizumab-combination-is-changing-practice-in-first-line-management-of-advanced-cervical-cancer\/"]}]},{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/aceoncology.org\/zh-hans\/pembrolizumab-combination-is-changing-practice-in-first-line-management-of-advanced-cervical-cancer\/#primaryimage","url":"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/10\/Picture-Blog-Post-61_Pembrizumab-1.jpg","contentUrl":"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/10\/Picture-Blog-Post-61_Pembrizumab-1.jpg","width":1736,"height":1528},{"@type":"BreadcrumbList","@id":"https:\/\/aceoncology.org\/zh-hans\/pembrolizumab-combination-is-changing-practice-in-first-line-management-of-advanced-cervical-cancer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"ACE Oncology","item":"https:\/\/aceoncology.org\/zh-hans\/chinese-home\/"},{"@type":"ListItem","position":2,"name":"\u5e15\u535a\u5229\u73e0\u5355\u6297\u8054\u5408\u6cbb\u7597\u66f4\u65b0\u665a\u671f\u5bab\u9888\u764c\u4e34\u5e8a\u5b9e\u8df5"}]},{"@type":"WebSite","@id":"https:\/\/aceoncology.org\/#website","url":"https:\/\/aceoncology.org\/","name":"ACE Oncology","description":"ACE Oncology is a global independent medical education resource that provides evidence-based, high-quality educational solutions for clinicians that treat patients with cancer.","publisher":{"@id":"https:\/\/aceoncology.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/aceoncology.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"zh-Hans"},{"@type":"Organization","@id":"https:\/\/aceoncology.org\/#organization","name":"ACE Oncology","url":"https:\/\/aceoncology.org\/","logo":{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/aceoncology.org\/#\/schema\/logo\/image\/","url":"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/05\/Logo.png","contentUrl":"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/05\/Logo.png","width":156,"height":83,"caption":"ACE Oncology"},"image":{"@id":"https:\/\/aceoncology.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/ace_oncology","https:\/\/www.linkedin.com\/company\/aceoncology"]},{"@type":"Person","@id":"https:\/\/aceoncology.org\/#\/schema\/person\/b551dd0a4b75a5b349e0a71560a8b3c0","name":"ACE Demo","image":{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/aceoncology.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/5364d75bb683367c9b56b8d9914df888527c9d170b78bbc5ef94bb01125a2253?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/5364d75bb683367c9b56b8d9914df888527c9d170b78bbc5ef94bb01125a2253?s=96&d=mm&r=g","caption":"ACE Demo"},"url":"https:\/\/aceoncology.org\/zh-hans\/author\/demo\/"}]}},"_links":{"self":[{"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/posts\/2802","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/comments?post=2802"}],"version-history":[{"count":4,"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/posts\/2802\/revisions"}],"predecessor-version":[{"id":2836,"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/posts\/2802\/revisions\/2836"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/media\/2720"}],"wp:attachment":[{"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/media?parent=2802"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/categories?post=2802"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/tags?post=2802"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}